Navigation Links
Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
Date:8/19/2007

on. Patients who achieved a partial response, or had stable disease lasting through Week 52, were eligible for re-treatment, a booster, using the same protocol and dose as the initial treatment. Endpoints included safety, immunologic activity and antitumor activity.

Study Results

Treatment with NEUVENGE was generally well tolerated. The majority of side effects were mild, including infusion-related fever and chills that were usually of low grade and typically lasted for one to two days following infusion. No patient discontinued the trial because of toxicity.

Treatment with NEUVENGE stimulated significant immune responses, which were shown to be enhanced following booster infusions. Twenty-two percent of patients had evidence of anti-cancer activity. This included one patient who experienced a partial response lasting approximately 6 months and three patients who had stable disease for over a year (74.9-94.0 weeks) without the addition of any other cancer therapy other than the continuation of bisphonates. Two additional patients had stable disease for up to 20 weeks. The study concluded that NEUVENGE was feasible, well-tolerated and showed evidence of anti-cancer activity.

"We are pleased that the results from this Phase I study of NEUVENGE demonstrate its potential as a treatment for advanced breast cancer patients," said Mark Frohlich, M.D., vice president of clinical affairs at Dendreon. "These data, together with the data we have published on the use of Provenge(R) (sipuleucel-T) in prostate cancer, further substantiate the promise of active cellular immunotherapies as new treatments for different types of cancer."

About NEUVENGE

NEUVENGE (lapuleucel-T) is an investigational product in a new class of active cellular immunotherapies (ACIs) that are uniquely designed to stimulate a patient's own immune system. ACIs hold promise because they may provide patients with a meaningful clinical benefit with low toxicities. NEUVENGE is
'/>"/>

SOURCE Dendreon Corporation

Copyright©2007 PR Newswire.

Page: 1 2 3 4

Related medicine technology :

1. Dendreon Announces Presentation of Data at American Urological Association Annual Meeting
2. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
3. Sygnis Pharma AG announces date for presentation of clinical results
4. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
6. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
7. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
8. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
9. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
10. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
11. Protox Announces Positive Clinical Data from Prostate Cancer Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2015)... The saturated European market for infant care ... of preterm births. This trend is not only fuelling ... but also skilled and trained professionals to operate these ... Analysis of the Western European Infant Care Solutions Market, ... in 2014 and estimates this to reach $177.5 million ...
(Date:4/20/2015)...  Fewer blockbusters drugs are expected to go off-patent ... generic companies in Asia . Hence, ... the patent cliff to focus on market expansion and ... manufacturers are restructuring their business models and investing heavily ... impact of these efforts will take a minimum of ...
(Date:4/20/2015)... 20, 2015 /CNW/ - Dr. Gregory Taylor , ... Canada today after spending a week in ... the evolving situation and needs on the ground as global efforts ... focussed on treatment and prevention efforts in Sierra Leone ... was able to see first-hand the work being done and hear ...
Breaking Medicine Technology:Rising Numbers of Preterm Births Stoke Demand for Infant Care Solutions in Europe 2Rising Numbers of Preterm Births Stoke Demand for Infant Care Solutions in Europe 3Generic Drug Companies in Asia Focus More on Market Expansion and Quality, Less on Patent Cliff, Finds Frost & Sullivan 2Generic Drug Companies in Asia Focus More on Market Expansion and Quality, Less on Patent Cliff, Finds Frost & Sullivan 3Generic Drug Companies in Asia Focus More on Market Expansion and Quality, Less on Patent Cliff, Finds Frost & Sullivan 4Generic Drug Companies in Asia Focus More on Market Expansion and Quality, Less on Patent Cliff, Finds Frost & Sullivan 5Canada's Efforts Making a Difference in the Fight Against Ebola 2Canada's Efforts Making a Difference in the Fight Against Ebola 3Canada's Efforts Making a Difference in the Fight Against Ebola 4Canada's Efforts Making a Difference in the Fight Against Ebola 5
(Date:4/21/2015)... California (PRWEB) April 21, 2015 On ... Movie Awards” EcoLuxe Lounge at the world famous Avalon ... of sustainable product placement in TV and film, the ... makes appearances at many awards ceremonies and festivals throughout ... top providers of eco-friendly and socially conscious products and ...
(Date:4/21/2015)... The 2015 Market Research Report ... professional and in-depth study on the current state ... with a focus on the Chinese situation. ... market research are Cargill, Fbc Industries, Posy Pharmachem, ... Capchem, Lianyungang Mupro Fi, Yixing-Union, Debang Fine Chemical, ...
(Date:4/21/2015)... April 21, 2015 This year, in ... Skin Types, Inc.® (FIRST) will publish a unique awareness ... will run throughout the month of May and carry ... to Someone." The positioning was chosen to encourage ... skin disorder and to help support our mission of ...
(Date:4/21/2015)... Further strengthening ties between the two institutions, ... goods and services to the University of South Florida ... BRIDGE Healthcare Clinic. , The BRIDGE clinic – a ... year – provides primary medical care to more than ... inside the USF Health Morsani Center for Advanced Healthcare. ...
(Date:4/21/2015)... Approximately 75 million Americans live in areas ... Agency (EPA). On top of this, consuming alcohol and ... level of toxins found in the body. A natural ... is to increase consumption of broccoli. Considered by many ... glucoraphanin – a long-lasting antioxidant – of all cruciferous ...
Breaking Medicine News(10 mins):Health News:Hollywood's Santana Dempsey and Choices Recovery South Bend Examine Victory over Personal Struggles 2Health News:Sodium Citrate Industry Global Key Manufacturers Analysis Report 2015-2020 2Health News:Sodium Citrate Industry Global Key Manufacturers Analysis Report 2015-2020 3Health News:May is Ichthyosis Awareness Month. Use Your Voice. 2Health News:USF Health and Florida Hospital Tampa Partner to Expand BRIDGE Clinic 2Health News:USF Health and Florida Hospital Tampa Partner to Expand BRIDGE Clinic 3Health News:New Survey Shows Americans Are Cooking the Health Out of Broccoli 2Health News:New Survey Shows Americans Are Cooking the Health Out of Broccoli 3
... ,Coping With Unseen Injuries: From Battlefield to HomeFront, , , ... y Officers Association of America (MOAA) and the ... (USNI) will host a one-day Defense Forum Washington - "Coping With ... Hilton Alexandria Mark Center, 5000 Seminary Road in Alexandria, Va. Admiral Mike Mullen, USN, ...
... 2009 AMERIGROUP Corporation (NYSE: AGP ) will host an ... held at the Grand Hyatt Hotel in New York City. The ... 8:30 a.m. Eastern Time. , , To access ... Web site, www.amerigroupcorp . com , approximately ...
... , , , ... this time from the trading floor. While there has long been ... new research by the Kellogg School of Management at Northwestern University, ... of Chicago,s Department of Comparative Human Development explores how the hormone ...
... Experts recommend far fewer teaspoons a day than average person ... American women should not consume more than 100 calories ... intake to no more than 150 calories, according to a ... refers to sugars added to foods during processing, during cooking ...
... Questions Health Care Reform Benefits for Illegal Aliens, Supports Continued Immigration ... The Federation for American Immigration Reform (FAIR) announces September ... Their Feet to the Fire radio rally in ... 47 hosts, led by Roger Hedgecock of Radio America Networks and ...
... , , , ... Simmons firm, a leading national law firm in the fight against ... of the foremost trial attorneys in the country, has joined the ... tried dozens of asbestos cancer cases since the late 1970s. He ...
Cached Medicine News:Health News:Chairman of the Joint Chiefs of Staff to Discuss Wounded Warrior Issues at the USNI & MOAA 2009 Defense Forum Washington 2Health News:Chairman of the Joint Chiefs of Staff to Discuss Wounded Warrior Issues at the USNI & MOAA 2009 Defense Forum Washington 3Health News:Risky Business: New Study Explores Role of Gender, Testosterone in Financial Risk Aversion 2Health News:Risky Business: New Study Explores Role of Gender, Testosterone in Financial Risk Aversion 3Health News:Risky Business: New Study Explores Role of Gender, Testosterone in Financial Risk Aversion 4Health News:Americans Are Urged to Cut Sugar Intake 2Health News:Radio Talk Hosts Prepare for Broadcast Blitz Live From Washington. D.C. 2Health News:Decorated Trial Attorney Conard Metcalf Joins Simmons Firm as 'Of Counsel' 2Health News:Decorated Trial Attorney Conard Metcalf Joins Simmons Firm as 'Of Counsel' 3
... Radial Microtome has a look that is revolutionary, ... of functions and capabilities that will please the ... of experience and knowledge but still breaking new ... Microtome will be the answer to many of ...
This is an economical (portable) microtome designed for fast and accurate sectioning. The specimen rise is automatic and accurate with each handle movement. Section thickness from 5 to 40 microns. ...
Coarse abrasive for knife sharpening, 6 grams net...
... Cryostage freezing stage is a refrigerated design for ... primarily for use with the 8000 sledge microtome, ... microtomes. ,The refrigerated stage gives a large working ... is ridged to provide good adhesion between the ...
Medicine Products: